⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GALT News
Galectin Therapeutics Inc.
Complicated Urinary Tract Infections Market Report, Analyzes Treatment Needs Across Elderly, Diabetic, and Immunosuppressed Populations
globenewswire.com
ABBV
PFE
GALT
VKTX
LPCN
ALGS
LLY
Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
globenewswire.com
GALT
Form 8-K
sec.gov
GALT
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
globenewswire.com
GALT
Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update
globenewswire.com
GALT
Form 8-K
sec.gov
GALT
Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology
globenewswire.com
GALT
Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
GALT
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
globenewswire.com
GALT
Form 8-K
sec.gov
GALT